Immunoassay Market Worth $46.49 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research®

Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Analyzers, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecast to 2028

London, Jan. 18, 2022 (GLOBE NEWSWIRE) -- According to a new market research report Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Platform, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecast to 2028”, published by Meticulous Research®, the immunoassay market is expected to grow at a CAGR of 7.5% from 2021 to reach $46.49 billion by 2028.

Download Free Sample Report Now @

Immunoassays are bioanalytical methods that use the specificity of an antigen-antibody reaction to detect and quantify target molecules in biological samples. These methods are frequently used in clinical diagnostics, drug discovery, drug monitoring, and food testing. Immunoassays have played a vital role in pharmaceutical analysis, such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetics, and bioequivalence studies in drug discovery and pharmaceutical industries. The immunoassays industry is growing steadily due to various factors such as increased research and diagnosis for infectious disease testing as new pathogen strains develop each year. The market comprises kits & reagents, systems or analyzers, and software and services that can detect diseases or other conditions and can be used for research activities.

The immunoassay market is primarily segmented by product & solutions, platform, application, end user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

On the basis of product and solutions, the immunoassay kits and reagents segment accounted for the largest share of the overall immunoassay market in 2021. The largest share of this segment was mainly attributed to increasing number of immunoassay tests being performed globally, leading to recurrent purchases of kits and reagents, increasing focus on vaccine development to address challenges such as antimicrobial resistance and pandemics, and technological advancements in ELISpot assay kits. Furthermore, increase in demand for immunoassay based COVID-19 testing products along with cost-effectiveness of these products is likely to expand the growth of immunoassay kits and reagents segment in the upcoming years.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:

On the basis of platform, the chemiluminescence immunoassays segment accounted for the largest share of the overall immunoassay market in 2021. Factors such as increasing adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis due to low cost per test, and requirement of simple equipment, propel the segment growth.

On the basis of application, the infectious diseases segment accounted for the largest share of immunoassay market in 2021 owing to recent regulatory approvals for infectious disease screening products, product launches, rising incidence of infectious diseases, and an increase in the availability of COVID-19 test kits across the globe.

On the basis of end user, immunoassay market is broadly segmented into diagnostic reference laboratories, hospitals & clinics, research and academic laboratories, pharmaceutical and biotechnology companies, and other end users which comprises of nursing homes, ambulatory care centers, blood banks, and home healthcare agencies. In 2021, the diagnostic reference laboratories segment accounted for largest share of the overall immunoassay market. Rising level of laboratory automation, rise in the patient volume leading towards the rise in the number of tests being carried out in the diagnostic labs, availability of well-equipped immunoassay systems and skilled labor, growing prevalence of infectious diseases, and rising government initiatives are the factors supporting the largest share of diagnostic reference laboratories end user segment. However, the hospitals & clinics segment is expected to grow fastest during the forecast period due to the growing patient population, rising Medicare reimbursement for clinical tests performed in hospitals, and improving healthcare infrastructure.

Quick Buy – Immunoassay Market Research Report:

On the basis of geography, the global immunoassays market is mainly divided into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share which can be attributed to the rising prevalence of various infectious diseases, well-established healthcare sector, higher awareness regarding early disease diagnosis, increasing penetration of advanced medical devices, and increasing funding activities coupled with the development of novel advanced immunoassay solutions.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years. The immunoassay market has witnessed number of new product launches, approvals, agreements, collaborations, partnerships, & expansions in recent years. For instance, in April 2021, F. Hoffmann-La Roche AG (Switzerland) launched Elecsys Anti-p53 immunoassay for the detection of anti-p53 antibodies in cancer patients. The test is used in patients with bowel cancer, oesophageal cancer, and breast cancer. In September 2020, Siemens Healthineers AG (Germany) collaborated with Novartis Pharma AG (Switzerland), a pharmaceutical company, to support Novartis’s therapeutic pipeline by developing assays, primarily for serum neurofilament light chain (sNFL) immunoassay. The collaboration was also made to support Novartis’ MS and other neuroscience programs.

The key players operating in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and PerkinElmer, Inc. (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here:

Scope of the Report:

Immunoassay Market, by Product & Solutions

  • Immunoassay Kits and Reagents
    • Elisa Kits and Reagents
    • Rapid Test Kits and Reagents
    • Western Blot Kits and Reagents
    • ELISPOT Kits and Reagents
    • Other Immunoassay Kits and Reagents
  • Immunoassay Analyzers
  • Immunoassay Software and Services

Other immunoassay kits and reagents comprises of plasmon resonance-based immunoassays, radioimmunoassay, microfluidic assays, and nanomaterial and micro-material-based assays

Global Immunoassay Market, by Platform

  • Chemiluminescence Immunoassays
  • Fluorescence Immunoassays
  • Colorimetric Immunoassays
  • Radioimmunoassay
  • Other Immunoassay Platforms

Other immunoassay platforms comprise of turbidimetric immunoassays and counting immunoassays

Immunoassay Market, by Application

  • Infectious Diseases
  • Oncology
  • Endocrinology
  • Cardiology
  • Bone and Mineral Diseases
  • Autoimmune Diseases
  • Other Applications

Other applications comprise of toxicology, hematology, neonatal testing, allergy, and astrology

Immunoassay Market, by End Users

  • Diagnostics Reference Laboratories
  • Hospitals and Clinics
  • Research and Academic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Other end users comprise of nursing homes, ambulatory care centers, blood banks, and home healthcare agencies
Immunoassay Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Indonesia
    • Rest of APAC (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Download Free Sample Report Now @

     Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-

Related Reports:

In-vitro Diagnostics Market (IVD Market) by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) – Forecast to 2027

Lateral Flow Assays Market by Product (Kits, Readers), Technique (Sandwich, Competitive, Multiplex), Application (Clinical [Pregnancy, Infectious Diseases], Food Safety, Drug Development, Veterinary), and End User (Hospitals, Home Care) - Forecast to 2027

Influenza Diagnostics Market by Test Type {[Traditional (RIDT, Direct Fluorescent Antibody, Viral Culture, Serology), Molecular [RT-PCR, INAAT (NASBA, LAMP)]}, End User (Hospitals, Laboratories, Academics, Research Institutes) - Global Forecast to 2027

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Oligonucleotide, Nucleic Acid Probe), Technology (Immunoassay, Hematology, Microbiology), Use (Research, Analyte Specific Reagent), End User (IVD Manufacturer, Clinical Laboratory) – Global Forecast to 2027

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding, 
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Visit Our Website:
Connect with us on LinkedIn-
Content Source:


Contact Data